155 related articles for article (PubMed ID: 24681532)
21. Colorectal cancer screening: physician attitudes and practices.
Taylor ML; Anderson R
WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
[TBL] [Abstract][Full Text] [Related]
22. Public awareness of colorectal cancer in a Turkish population: importance of fecal occult blood testing.
Bas K; Guler T; Gunay LM; Besim H; Uygur D
Asian Pac J Cancer Prev; 2012; 13(1):195-8. PubMed ID: 22502667
[TBL] [Abstract][Full Text] [Related]
23. Colorectal cancer screening in Canada: results of a national survey.
Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
[TBL] [Abstract][Full Text] [Related]
25. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
26. Patterns of colorectal cancer screening uptake among men and women in the United States.
Meissner HI; Breen N; Klabunde CN; Vernon SW
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
[TBL] [Abstract][Full Text] [Related]
27. Do benefits and barriers differ by stage of adoption for colorectal cancer screening?
Rawl SM; Menon U; Champion VL; May FE; Loehrer P; Hunter C; Azzouz F; Monahan PO; Skinner CS
Health Educ Res; 2005 Apr; 20(2):137-48. PubMed ID: 15314036
[TBL] [Abstract][Full Text] [Related]
28. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
29. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
30. Vital signs: colorectal cancer screening among adults aged 50-75 years - United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jul; 59(26):808-12. PubMed ID: 20613704
[TBL] [Abstract][Full Text] [Related]
31. Self-reported colonoscopy screening in Austria.
Haidinger G; Waldhoer T; Vutuc C
Eur J Cancer Prev; 2008 Aug; 17(4):354-7. PubMed ID: 18562961
[TBL] [Abstract][Full Text] [Related]
32. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
33. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
Loss J; Eichhorn C; Nagel E
Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
[TBL] [Abstract][Full Text] [Related]
34. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
35. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
[TBL] [Abstract][Full Text] [Related]
36. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
[TBL] [Abstract][Full Text] [Related]
37. Are there gender differences in colorectal cancer test use prevalence and correlates?
McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
[TBL] [Abstract][Full Text] [Related]
38. [Knowledge of colorectal cancer prevention in the Bavarian population above 50 years--survey in two districts].
Loss J; Eichhorn C; Nagel E
Gesundheitswesen; 2005 Jul; 67(7):455-60. PubMed ID: 16103968
[TBL] [Abstract][Full Text] [Related]
39. Colonoscopy and fecal occult blood test use in Germany: results from a large insurance-based cohort.
Stock C; Ihle P; Schubert I; Brenner H
Endoscopy; 2011 Sep; 43(9):771-81. PubMed ID: 21830189
[TBL] [Abstract][Full Text] [Related]
40. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
